Utility of PET-MRI in Surveillance of Paediatric Brain Tumours (NCT05553899) | Clinical Trial Compass
RecruitingNot Applicable
Utility of PET-MRI in Surveillance of Paediatric Brain Tumours
United Kingdom5 participantsStarted 2024-02-28
Plain-language summary
This is a pilot project to explore the utility of PET-MRI in the post-treatment surveillance of high-grade gliomas or medulloblastomas in children in our institution.
Who can participate
Age range8 Years – 18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Have a presumptive or histologically confirmed diagnosis of a malignant brain tumour requiring treatment
* Diagnostic uncertainty about tumour recurrence post-treatment based on conventional MR imaging in the opinion of the MDT
* Have a life expectancy of at least three months
* Able to comply with an MRI scan without a general anaesthetic
Exclusion Criteria:
* Unable to comply with an MRI scan without a general anaesthetic
* Diabetes or other causes of hyperglycaemia
* Pregnancy
* Patient body habitus above scanner dimensions
* Standard contra-indication to MRI (eg. pacemaker, non-compatible metallic implants, altered renal function)
What they're measuring
1
Determine number of patients able to recruited for study in one year